Registered Trials

• NCT05543356

  Phase 3

  Australia

  Total Enrollment: 800

  Official Trial Registration:

  • NCT05543356(Opens in new tab/window)

• NCT05323461

  Phase 3

  Total Enrollment: 1,800

  Official Trial Registration:

  • NCT05323461(Opens in new tab/window)

• NCT05556720

  Phase 3

  Australia

  Total Enrollment: 960

  Official Trial Registration:

  • NCT05556720(Opens in new tab/window)

• NCT05387317

  Phase 3

  Indonesia

  Total Enrollment: 800

  Official Trial Registration:

  • NCT05387317(Opens in new tab/window)

• NCT05228730

  Phase 3

  Australia

  Total Enrollment: 800

  Official Trial Registration:

  • NCT05228730(Opens in new tab/window)

• NCT05230953

  Phase 3

  Israel

  Total Enrollment: 1,000

  Official Trial Registration:

  • NCT05230953(Opens in new tab/window)

• NCT05048940

  Phase 3

  Spain

  Total Enrollment: 386

  Official Trial Registration:

  • NCT05048940(Opens in new tab/window)

• NCT05142319

  Phase 3

  Singapore

  Total Enrollment: 600

  Official Trial Registration:

  • NCT05142319(Opens in new tab/window)

• NCT05119855

  Phase 3

  United States of America

  Total Enrollment: 400

  Official Trial Registration:

  • NCT05119855(Opens in new tab/window)

• NCT05158140

  Phase 3

  Puerto Rico, United States of America

  Total Enrollment: 1,300

  Official Trial Registration:

  • NCT05158140(Opens in new tab/window)

• NCT04805125

  Phase 3

  Switzerland

  Total Enrollment: 380

  Official Trial Registration:

  • NCT04805125(Opens in new tab/window)

• NCT04470427

  Phase 3

  United States of America

  Total Enrollment: 30,420

  Official Trial Registration:

  • NCT04470427(Opens in new tab/window)

• NCT04806113

  Phase 3

  Canada

  Total Enrollment: 220

  Official Trial Registration:

  • NCT04806113(Opens in new tab/window)

• NCT04811664

  Phase 3

  United States of America

  Total Enrollment: 37,500

  Official Trial Registration:

  • NCT04811664(Opens in new tab/window)

• NCT04860297

  Phase 3

  United States of America

  Total Enrollment: 240

  Official Trial Registration:

  • NCT04860297(Opens in new tab/window)

• NCT04927065

  Phase 2/3

  United States of America

  Total Enrollment: 4,658

  Official Trial Registration:

  • NCT04927065(Opens in new tab/window)

• NCT05249829

  Phase 2/3

  United Kingdom of Great Britain and Northern Ireland

  Total Enrollment: 2,924

  Official Trial Registration:

  • NCT05249829(Opens in new tab/window)

• ISRCTN99890480

  Phase 2/3

  United Kingdom of Great Britain and Northern Ireland

  Total Enrollment: 2,924

  Official Trial Registration:

  • ISRCTN99890480(Opens in new tab/window)

• NCT05236491

  Phase 2/3

  Canada

  Total Enrollment: 287

  Official Trial Registration:

  • NCT05236491(Opens in new tab/window)

• NCT05022329

  Phase 2/3

  Canada

  Total Enrollment: 300

  Official Trial Registration:

  • NCT05022329(Opens in new tab/window)

• NCT05168813

  Phase 2/3

  Botswana, Eswatini, Kenya, Malawi, South Africa, Uganda, Zambia, Zimbabwe

  Total Enrollment: 14,000

  Official Trial Registration:

  • NCT05168813(Opens in new tab/window)

• NCT04649151

  Phase 2/3

  United States of America

  Total Enrollment: 3,000

  Official Trial Registration:

  • NCT04649151(Opens in new tab/window)

• NCT04796896

  Phase 2/3

  Canada, United States of America

  Total Enrollment: 13,275

  Official Trial Registration:

  • NCT04796896(Opens in new tab/window)

• NCT05383560

  Phase 2

  Israel

  Total Enrollment: 150

  Official Trial Registration:

  • NCT05383560(Opens in new tab/window)

• NCT05308602

  Phase 2

  Total Enrollment: 480

  Official Trial Registration:

  • NCT05308602(Opens in new tab/window)

• NCT05345873

  Phase 2

  Total Enrollment: 300

  Official Trial Registration:

  • NCT05345873(Opens in new tab/window)

• NCT05137236

  Phase 2

  United States of America

  Total Enrollment: 420

  Official Trial Registration:

  • NCT05137236(Opens in new tab/window)

• NCT05027672

  Phase 2

  Argentina

  Total Enrollment: 348

  Official Trial Registration:

  • NCT05027672(Opens in new tab/window)

• ISRCTN73765130

  Phase 2

  United Kingdom of Great Britain and Northern Ireland

  Total Enrollment: 2,664

  Official Trial Registration:

  • ISRCTN73765130(Opens in new tab/window)

• NCT05465902

  Phase 2

  Mexico

  Total Enrollment: 600

  Official Trial Registration:

  • NCT05465902(Opens in new tab/window)

• NCT05197153

  Phase 2

  Taiwan

  Total Enrollment: 960

  Official Trial Registration:

  • NCT05197153(Opens in new tab/window)

• NCT05324319

  Phase 2

  Austria

  Total Enrollment: 200

  Official Trial Registration:

  • NCT05324319(Opens in new tab/window)

• NCT05315362

  Phase 2

  Netherlands

  Total Enrollment: 20

  Official Trial Registration:

  • NCT05315362(Opens in new tab/window)

• NCT05000216

  Phase 2

  United States of America

  Total Enrollment: 2,340

  Official Trial Registration:

  • NCT05000216(Opens in new tab/window)

• NCT04894435

  Phase 2

  Canada

  Total Enrollment: 1,300

  Official Trial Registration:

  • NCT04894435(Opens in new tab/window)

• NCT04988048

  Phase 2

  Argentina

  Total Enrollment: 1,760

  Official Trial Registration:

  • NCT04988048(Opens in new tab/window)

• NCT04969263

  Phase 2

  United States of America

  Total Enrollment: 200

  Official Trial Registration:

  • NCT04969263(Opens in new tab/window)

• NCT05077254

  Phase 2

  United States of America

  Total Enrollment: 400

  Official Trial Registration:

  • NCT05077254(Opens in new tab/window)

• NCT04930770

  Phase 2

  Total Enrollment: 80

  Official Trial Registration:

  • NCT04930770(Opens in new tab/window)

• NCT04969276

  Phase 2

  United States of America

  Total Enrollment: 306

  Official Trial Registration:

  • NCT04969276(Opens in new tab/window)

• EUCTR2021-002348-57

  Phase 2

  Austria

  Total Enrollment: 60

  Official Trial Registration:

  • EUCTR2021-002348-57(Opens in new tab/window)

• NCT04761822

  Phase 2

  United States of America

  Total Enrollment: 3,400

  Official Trial Registration:

  • NCT04761822(Opens in new tab/window)

• NCT04405076

  Phase 2

  United States of America

  Total Enrollment: 660

  Official Trial Registration:

  • NCT04405076(Opens in new tab/window)

• NCT04748471

  Phase 2

  Total Enrollment: 180

  Official Trial Registration:

  • NCT04748471(Opens in new tab/window)

• NCT04847050

  Phase 2

  United States of America

  Total Enrollment: 120

  Official Trial Registration:

  • NCT04847050(Opens in new tab/window)

• jRCT2071210106

  Phase 1/2/3

  Japan

  Total Enrollment: 5,028

  Official Trial Registration:

  • jRCT2071210106(Opens in new tab/window)

• NCT05375838

  Phase 1/2

  United States of America

  Total Enrollment: 1,050

  Official Trial Registration:

  • NCT05375838(Opens in new tab/window)

• NCT04889209

  Phase 1/2

  United States of America

  Total Enrollment: 400

  Official Trial Registration:

  • NCT04889209(Opens in new tab/window)

• NCT05132855

  Phase 1/2

  Taiwan

  Total Enrollment: 400

  Official Trial Registration:

  • NCT05132855(Opens in new tab/window)

• NCT05280158

  Phase 1/2

  United States of America

  Total Enrollment: 60

  Official Trial Registration:

  • NCT05280158(Opens in new tab/window)

• NL9275

  Phase 1/2

  Netherlands

  Total Enrollment: 150

  Official Trial Registration:

  • NL9275(Opens in new tab/window)

• NCT04813796

  Phase 1

  United States of America

  Total Enrollment: 125

  Official Trial Registration:

  • NCT04813796(Opens in new tab/window)

• NCT04785144

  Phase 1

  United States of America

  Total Enrollment: 210

  Official Trial Registration:

  • NCT04785144(Opens in new tab/window)

• NCT04839315

  Phase 1

  United States of America

  Total Enrollment: 100

  Official Trial Registration:

  • NCT04839315(Opens in new tab/window)

• NCT04283461

  Phase 1

  United States of America

  Total Enrollment: 120

  Official Trial Registration:

  • NCT04283461(Opens in new tab/window)